創薬における人工知能(AI)の世界市場2020-2026:コンポーネント別(ソフトウェア、サービス)、技術別、用途別、エンドユーザー別、地域別

◆英語タイトル:Global Artificial Intelligence (AI) in Drug Discovery Market Size study, by Component (Software, Services), by Technology (Machine Learning, Deep Learning, Others), by Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers, Academic & Government Institutes) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年5月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、創薬における人工知能(AI)の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、コンポーネント別(ソフトウェア、サービス)分析、技術別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・創薬における人工知能(AI)の世界市場:コンポーネント別(ソフトウェア、サービス)
・創薬における人工知能(AI)の世界市場:技術別
・創薬における人工知能(AI)の世界市場:用途別
・創薬における人工知能(AI)の世界市場:エンドユーザー別
・創薬における人工知能(AI)の世界市場:地域別
・競争状況
【レポートの概要】

Global Artificial Intelligence (AI) in Drug Discovery Market is valued approximately at USD 260 million in 2019 and is anticipated to grow with a healthy growth rate of more than 40.7% over the forecast period 2019-2026. Artificial intelligence for drug discovery is a technology that uses distinct algorithms which add value in decision-making processes for drug discovery. The implementation of AI reduces the gap of researches and development in the drug manufacturing process and also help in the targeted of manufacturing of the drugs. For this reason, the biopharmaceutical industries are increasingly adopting AI technology to optimize the drug manufacturing process. Further, rising investment & funding in drug discovery, along with the surging need to control drug discovery & development costs and reduce time are the few factors responsible for high CAGR of the market over the forecast period. For instance, as per India Brand Equity Foundation, 2018, the Indian Government is planning a $640 million fund for boosting the drug discovery and pharmaceutical infrastructure. The initiative ‘Pharma Vision 2020’ of Indian Government has a goal for making India a major hub for drug discovery. This, in turn, is expected to accelerate the demand of artificial intelligence (AI) in drug discovery across the world. However, lack of awareness and high cost & technical limitation of AI decision-making are some major forces expected to impede the growth of global Artificial Intelligence (AI) in Drug Discovery market over the forecast period of 2020-2026.

The regional analysis of global Artificial Intelligence (AI) in Drug Discovery Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising focus on R&D & substantial investment, along with the high awareness of the AI in drug discovery among key players located in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period, due to constant technological advancements in the pharmaceutical sector and increasing number of pharmaceutical manufacturers in developing countries such as China and India.

Major market player included in this report are:
Microsoft Corporation
NVIDIA Corporation
IBM Corporation
Google Inc.
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals, Inc.
Insilico Medicine
Benevolentai
Exscientia

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Component:
Software
Services

By Technology:
Machine Learning
Deep Learning
Others

By Application:
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Others

By End-User:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers
Academic & Government Institutes

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Artificial Intelligence (AI) in Drug Discovery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Artificial Intelligence (AI) in Drug Discovery Market, by Component, 2018-2026 (USD Million)
1.2.2. Artificial Intelligence (AI) in Drug Discovery Market, by Technology, 2018-2026 (USD Million)
1.2.3. Artificial Intelligence (AI) in Drug Discovery Market, by Application, 2018-2026 (USD Million)
1.2.4. Artificial Intelligence (AI) in Drug Discovery Market, by End-User, 2018-2026 (USD Million)
1.2.5. Artificial Intelligence (AI) in Drug Discovery Market, by Region, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Artificial Intelligence (AI) in Drug Discovery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Artificial Intelligence (AI) in Drug Discovery Market Dynamics
3.1. Artificial Intelligence (AI) in Drug Discovery Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Artificial Intelligence (AI) in Drug Discovery Market, by Component
5.1. Market Snapshot
5.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Component, Performance – Potential Analysis
5.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Component 2016-2026 (USD Million)
5.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
5.4.1. Software
5.4.2. Services
Chapter 6. Global Artificial Intelligence (AI) in Drug Discovery Market, by Technology
6.1. Market Snapshot
6.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, Performance – Potential Analysis
6.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
6.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
6.4.1. Machine Learning
6.4.2. Deep Learning
6.4.3. Others
Chapter 7. Global Artificial Intelligence (AI) in Drug Discovery Market, by Application
7.1. Market Snapshot
7.2. Global Artificial Intelligence (AI) in Drug Discovery Market by Application, Performance – Potential Analysis
7.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by Application 2016-2026 (USD Million)
7.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
7.4.1. Immuno-Oncology
7.4.2. Neurodegenerative Diseases
7.4.3. Cardiovascular Diseases
7.4.4. Others
Chapter 8. Global Artificial Intelligence (AI) in Drug Discovery Market, by End-User
8.1. Market Snapshot
8.2. Global Artificial Intelligence (AI) in Drug Discovery Market by End-User, Performance – Potential Analysis
8.3. Global Artificial Intelligence (AI) in Drug Discovery Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
8.4. Artificial Intelligence (AI) in Drug Discovery Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Contract Research Organizations
8.4.3. Research Centers
8.4.4. Academic & Government Institutes
Chapter 9. Global Artificial Intelligence (AI) in Drug Discovery Market, Regional Analysis
9.1. Artificial Intelligence (AI) in Drug Discovery Market, Regional Market Snapshot
9.2. North America Artificial Intelligence (AI) in Drug Discovery Market
9.2.1. U.S. Artificial Intelligence (AI) in Drug Discovery Market
9.2.1.1. Component breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technology breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Artificial Intelligence (AI) in Drug Discovery Market
9.3. Europe Artificial Intelligence (AI) in Drug Discovery Market Snapshot
9.3.1. U.K. Artificial Intelligence (AI) in Drug Discovery Market
9.3.2. Germany Artificial Intelligence (AI) in Drug Discovery Market
9.3.3. Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market
9.4. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Snapshot
9.4.1. China Artificial Intelligence (AI) in Drug Discovery Market
9.4.2. India Artificial Intelligence (AI) in Drug Discovery Market
9.4.3. Japan Artificial Intelligence (AI) in Drug Discovery Market
9.4.4. Rest of Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market
9.5. Latin America Artificial Intelligence (AI) in Drug Discovery Market Snapshot
9.5.1. Brazil Artificial Intelligence (AI) in Drug Discovery Market
9.5.2. Mexico Artificial Intelligence (AI) in Drug Discovery Market
9.6. Rest of The World Artificial Intelligence (AI) in Drug Discovery Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Microsoft Corporation
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Component Summary
10.2.1.5. Recent Developments
10.2.2. NVIDIA Corporation
10.2.3. IBM Corporation
10.2.4. Google Inc.
10.2.5. Atomwise, Inc.
10.2.6. Deep Genomics
10.2.7. Cloud Pharmaceuticals, Inc.
10.2.8. Insilico Medicine
10.2.9. Benevolentai
10.2.10. Exscientia
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY COMPONENT 2016-2026 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. U.S. ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. CANADA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. UK ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. GERMANY ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. ROE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. CHINA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. INDIA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. JAPAN ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. ROAPAC ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. MEXICO ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROLA ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 58. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. ROW ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[創薬における人工知能(AI)の世界市場2020-2026:コンポーネント別(ソフトウェア、サービス)、技術別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆